Sotera Health Company Common Stock (SHC) — 分析摘要
Sotera Health Company Common Stock(SHC)的市值为5.18十亿美元,最近一年的营收同比增长了+5.7%。净利润率为6.7%。当前市盈率为44.0倍。
核心要点
- 营收同比变化+5.7%
- 净利润率6.7%
- 市盈率44.0倍
与SERVICES-MISC HEALTH & ALLIED SERVICES, NEC板块的其他公司相比,SHC的营收增长为+5.7%,市盈率为44.0倍。
Sotera Health Company Common Stock (SHC)
更新 — ET · 来源 POLYGON
红旗与风险提示高风险信号
存在多项实质性红旗,在依赖任何估值输出前应先重点核查这些风险。
Debt/EBITDA 为 7.1x — 高杠杆,存在再融资风险
D/E 为 3.4x — 财务杠杆偏高
Sotera Health Co provides sterilization, analytical lab testing, and advisory services to help ensure that medical, pharmaceutical, and food products are safe for healthcare practitioners, patients, and consumers. The company operates in three reportable segments: Sterigenics, Nordion, and Nelson Labs. The Sterigenics segment, which generates maximum revenue, provides outsourced terminal sterilization and irradiation services for medical devices, pharmaceuticals, food safety, and other application markets using three core technologies: gamma irradiation, EO processing, and E-beam irradiation. Geographically, the company generates maximum revenue from the United States, followed by Canada, Europe, and other regions.
行业
SERVICES-MISC HEALTH & ALLIED SERVICES, NEC
员工人数
3,000
总部
BROADVIEW HEIGHTS, OH
Exchange
XNAS
基于 4 年财务数据的系统性竞争优势评估
此评估基于历史财务数据的量化分析,不构成投资建议。护城河评级可能随行业和竞争环境变化。
首版展示近期 SEC Forms 3、4、5 备案活动。尚未解析单笔买入/卖出交易。
资本结构
现金流
免责声明:本站内容不构成投资建议。数据来源于SEC EDGAR和Polygon.io。过往业绩不代表未来表现。投资决策前请自行研究。